I agree. Look for the relist in late June early July. I think the first player in the market will be the diabetic wound treatment. As it is a topical FDA approval should be quick as trials have been completed. Hopefully we should see some press releases immediately upon relisting to take downward pressure off the stock. I believe that is CVBTs strategy. No doubt many are frustrated and there will be some dumping early. imo
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.